Menu
Sign In Search Podcasts Charts Entities Add Podcast API Pricing

Lars Sorensen

👤 Person
12 appearances

Podcast Appearances

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

I am on the headphones now.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

I am on the headphones now.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

It's difficult for me to pass judgment on. I think it's about on par.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

It's difficult for me to pass judgment on. I think it's about on par.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

So I think both companies benefit from this very intense competition.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

So I think both companies benefit from this very intense competition.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

And so I only welcome it. I would have been more worried if we didn't have competition because then there's always... the risks that complacency sets in.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

And so I only welcome it. I would have been more worried if we didn't have competition because then there's always... the risks that complacency sets in.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

I am on the headphones now.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

It's difficult for me to pass judgment on. I think it's about on par.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

So I think both companies benefit from this very intense competition.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

And so I only welcome it. I would have been more worried if we didn't have competition because then there's always... the risks that complacency sets in.